贵阳医学院学报
貴暘醫學院學報
귀양의학원학보
JOURNAL OF GUIYANG MEDICAL COLLEGE
2015年
6期
603-607
,共5页
傅碧玲%邹世海%彭鑫%翁俊雄%邓柳霞
傅碧玲%鄒世海%彭鑫%翁俊雄%鄧柳霞
부벽령%추세해%팽흠%옹준웅%산류하
肌细胞,平滑肌%血管%高磷%高钙%核心结合因子α1(Cbfα1)%骨钙素%α-平滑肌肌动蛋白(α-SMA)
肌細胞,平滑肌%血管%高燐%高鈣%覈心結閤因子α1(Cbfα1)%骨鈣素%α-平滑肌肌動蛋白(α-SMA)
기세포,평활기%혈관%고린%고개%핵심결합인자α1(Cbfα1)%골개소%α-평활기기동단백(α-SMA)
myocytes,smooth muscle%blood vessels%high phosphate%high calcium%vascular calci-fication%core binding factor α1%osteocalcin%α-smooth muscle actin
目的:探讨高磷及高钙诱导血管平滑肌细胞发生钙化的分子机制。方法:以人血管平滑肌细胞( VSMCs)为模型,采用不同钙磷浓度的培养基与细胞共培养12 d,将细胞分为正常钙、磷组(对照组)、高磷组、高钙组和高磷﹢高钙组,分别采用免疫印迹( western-blot)技术、逆转录-聚合酶链反应( RT-PCR)技术检测人血管平滑肌细胞核心结合因子α1(Cbfα1)、骨钙素、α-平滑肌肌动蛋白(α-SMA)蛋白质和mRNA的表达;高磷﹢高钙条件孵育下的细胞加入ZVAD-FMK干预后,再次采用western-blot技术检测Cbfα1、骨钙素蛋白质表达的情况。结果:试验组Cbfα1、骨钙素表达增强( P=0.013;P=0.007),而肌成纤维细胞的特异性标志物α-SMA表达下降(P=0.009),对照组上述3个指标无明显变化(P=0.055、P=0.074、P=0.63);加入ZVAD-FMK与高磷﹢高钙组细胞共培养后,Cbfα1、骨钙素蛋白质的表达受到明显抑制。结论:高磷或(和)高钙通过使血管平滑肌细胞转化为成骨样细胞而导致钙化的发生;ZVAD-FMK可以在一定程度上抑制这一病理生理进程,提示凋亡和成骨分化均参与了钙化过程。
目的:探討高燐及高鈣誘導血管平滑肌細胞髮生鈣化的分子機製。方法:以人血管平滑肌細胞( VSMCs)為模型,採用不同鈣燐濃度的培養基與細胞共培養12 d,將細胞分為正常鈣、燐組(對照組)、高燐組、高鈣組和高燐﹢高鈣組,分彆採用免疫印跡( western-blot)技術、逆轉錄-聚閤酶鏈反應( RT-PCR)技術檢測人血管平滑肌細胞覈心結閤因子α1(Cbfα1)、骨鈣素、α-平滑肌肌動蛋白(α-SMA)蛋白質和mRNA的錶達;高燐﹢高鈣條件孵育下的細胞加入ZVAD-FMK榦預後,再次採用western-blot技術檢測Cbfα1、骨鈣素蛋白質錶達的情況。結果:試驗組Cbfα1、骨鈣素錶達增彊( P=0.013;P=0.007),而肌成纖維細胞的特異性標誌物α-SMA錶達下降(P=0.009),對照組上述3箇指標無明顯變化(P=0.055、P=0.074、P=0.63);加入ZVAD-FMK與高燐﹢高鈣組細胞共培養後,Cbfα1、骨鈣素蛋白質的錶達受到明顯抑製。結論:高燐或(和)高鈣通過使血管平滑肌細胞轉化為成骨樣細胞而導緻鈣化的髮生;ZVAD-FMK可以在一定程度上抑製這一病理生理進程,提示凋亡和成骨分化均參與瞭鈣化過程。
목적:탐토고린급고개유도혈관평활기세포발생개화적분자궤제。방법:이인혈관평활기세포( VSMCs)위모형,채용불동개린농도적배양기여세포공배양12 d,장세포분위정상개、린조(대조조)、고린조、고개조화고린﹢고개조,분별채용면역인적( western-blot)기술、역전록-취합매련반응( RT-PCR)기술검측인혈관평활기세포핵심결합인자α1(Cbfα1)、골개소、α-평활기기동단백(α-SMA)단백질화mRNA적표체;고린﹢고개조건부육하적세포가입ZVAD-FMK간예후,재차채용western-blot기술검측Cbfα1、골개소단백질표체적정황。결과:시험조Cbfα1、골개소표체증강( P=0.013;P=0.007),이기성섬유세포적특이성표지물α-SMA표체하강(P=0.009),대조조상술3개지표무명현변화(P=0.055、P=0.074、P=0.63);가입ZVAD-FMK여고린﹢고개조세포공배양후,Cbfα1、골개소단백질적표체수도명현억제。결론:고린혹(화)고개통과사혈관평활기세포전화위성골양세포이도치개화적발생;ZVAD-FMK가이재일정정도상억제저일병리생리진정,제시조망화성골분화균삼여료개화과정。
Objective:To investigate the effect and molecular mechanism of high phosphate and high calcium on calcification of human vascular smooth muscle cells( VSMCs ). Methods:The human VSMCs were co-cultured with culture medium of different dose of phosphate and calcium in vitro for 12 days and according to dosage of calcium and phosphate the cells were divided into 5 groups as follows:normal calcium and phosphate group( control group,P 1. 4 mmol/L,Ca 2. 0 mmol/L),high phos-phate group(P 2. 0 mmol/L,Ca2. 0 mmol/L),high calcium group(P 1. 4 mmol/L,Ca 2. 8 mmol/L),high calcium and high phosphate group(P 2. 0mmol/L,Ca 2. 8mmol/L). Western-blot and RT-PCR were adopted to detect the protein and mRNA expression of Cbfα1,osteocalcin,α-SMA respec-tively. In high calcium and high phosphate group,the nonspecific inhibitor ZVAD-FMK of caspase was added in. After this intervention,western-blot was adopted again to detect protein expression of Cbfα1and osteocalcin. Results:Compared with control group,the expression of Cbfα1 and osteocalcin increased in all experimental groups while the expression of α-SMA,which was the specific marker of myofibroblast,decreased(P<0. 05). There were no obvious changes in the above-mentioned 3 indica-tors in the control group( P>0. 05 ). After ZVAD-FMK was added in and co-cultured with cells of high calcium and high phosphate group,the protein expression of Cbfα1and osteocalcin were inhibited obvi-ously. Conclusion:High concentration of phosphate or( and)calcium can induce calcification of hu-man VSMCs through turning VSMCs into osteoblast like cell( OLCs ). ZVAD-FMK can inhibit this pathophysiological process to a certain extent,which reveals that both apoptosis and osteogenic differ-entiation of VSMCs involve in the calcification process.